IL-10 as a mediator in the HPA axis and brain

被引:91
|
作者
Smith, EM [1 ]
Cadet, P
Stefano, GB
Opp, MR
Hughes, TK
机构
[1] Univ Texas, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA
[3] SUNY Coll Old Westbury, Neurosci Res Inst, Old Westbury, NY 11568 USA
关键词
neuroendocrine hormones; neuroimmunomodulation; cytokines; lymphocytes; pituitary;
D O I
10.1016/S0165-5728(99)00206-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Certain functional interactions between the nervous, endocrine, and immune systems are mediated, by cytokines. The pro-inflammatory cytokines, interleukin-l (IL-I) and tumor necrosis factor (TNF) were among the first to be recognized in this regard. A modulator of these cytokines, IL-10, has been shown to have a wide range of activities in the immune system; in this review, wa describe its production and actions in the hypothalamic-pituitary-adrenal (HPA) axis. IL-10 is produced in pituitary, hypothalamic, and neural tissues in addition to lymphocytes. IL-10 enhances corticotropin releasing factor (CRF) and corticotropin (ACTH) production in hypothalamic and pituitary tissues, respectively. Further downstream in the HPA axis endogenous IL-10 has the potential to contribute to regulation of glucocorticosteroid production both tonically and following stressors. Our studies and those of others reviewed here indicate that IL-10 may be an important endogenous regulator in IIPA axis activity and in CNS pathologies such as multiple sclerosis. Thus, in addition to its more widely recognized role in immunity, IL-10's neuroendocrine activities described here point to its role as an important regulator in communication between the immune and neuroendocrine systems. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:140 / 148
页数:9
相关论文
共 50 条
  • [21] IL-10 and IL-10 receptor overexpression in oral giant cell lesions
    Syrio, Narriman-Fatima-Lima
    Faria, Daniela-Rodrigues
    Gomez, Ricardo-Santiago
    Gollob, Kenneth-John
    Dutra, Walderez-Ornelas
    Souza, Paulo-Eduardo-Alencar
    [J]. MEDICINA ORAL PATOLOGIA ORAL Y CIRUGIA BUCAL, 2011, 16 (04): : E488 - E492
  • [22] Caveats regarding the use of IL-10 and IL-10 antagonist as immunotherapeutic factors
    Colino, Jesus
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2007, 4 (07) : 487 - 495
  • [23] IL-10 inhibits IFNγ and autoregulates IL-10 signaling through SOCSs
    Ding, YZ
    Qin, LH
    Su, RT
    Bromberg, JS
    [J]. FASEB JOURNAL, 2002, 16 (04): : A313 - A314
  • [24] IL-10 -1082 SNP and IL-10 in primary CNS and vitreoretinal lymphomas
    Hema L. Ramkumar
    De Fen Shen
    Jingsheng Tuo
    Rita M. Braziel
    Sarah E. Coupland
    Justine R. Smith
    Chi-Chao Chan
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2012, 250 : 1541 - 1548
  • [25] IL-10 secretion in relation to the haplotypic structure of the human IL-10 locus
    Eskdale, J
    Gallagher, G
    Verweij, C
    Keijers, V
    Westendorp, R
    Huizinga, T
    [J]. ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 1153 - 1153
  • [26] Further characterisation of cytokines in macropod marsupials: IL-10 and IL-10Δ3
    Alsemgeest, Jenifer
    Old, Julie M.
    Young, Lauren J.
    [J]. CYTOKINE, 2016, 88 : 37 - 44
  • [27] Cytokines and acute brain injury:: Focus on IL-1, IL-10, and TGFβ
    Toulmond, S
    [J]. BRAIN AND BIODEFENCE, 1998, 21 : 63 - 72
  • [28] mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection
    Cheekatla, Satyanarayana
    Aggarwal, Amita
    Naik, Sita
    [J]. JOURNAL OF IMMUNOLOGY, 2011, 186
  • [29] mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection
    Cheekatla, Satyanarayana Swamy
    Aggarwal, Amita
    Naik, Sita
    [J]. MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2012, 201 (01) : 37 - 46
  • [30] mTOR signaling pathway regulates the IL-12/IL-10 axis in Leishmania donovani infection
    Satyanarayana Swamy Cheekatla
    Amita Aggarwal
    Sita Naik
    [J]. Medical Microbiology and Immunology, 2012, 201 : 37 - 46